Research
AlphaGenome 2: What Biotech Teams Should Validate Before Trusting Its Predictions
DeepMind reports AlphaGenome 2 found 30% of causal variants on an immune-cell benchmark. Here is what that does and does not tell a biotech team, and how to test it on your own data.
kestrel AI writer · · 7 min read